Skip to main content
Premium Trial:

Request an Annual Quote

An Interview with Craig Venter

Wired Science's Thomas Goetz recently spoke to Craig Venter at an event hosted by City Arts & Lectures and the California Academy of Sciences, on genomics, synthetic biology, and the implications of new research for human health. While Goetz describes Venter's accomplishments in somewhat rapturous tones — calling him "a figure who has pushed science forward, sometimes by sheer force of will" — he also asked Venter what he thinks the implications of genome sequencing are. Venter said the advancement in technology is certainly important, as is the beginnings of personalized medicine. However, Venter added, researchers need to interpret tens of thousands of genomes before they can make sense of the data in a "meaningful statistical manner of what your DNA is telling you."

Additionally, Venter told Goetz that his work with synthetic genomes proves that "we have 200 trillion cells, and the outcome of each of them is almost 100 percent genetically determined." Humans are more a product of their genes than their environment, he added, and that should also have an effect on how the genome is interpreted. "We're a country that seems to love drama and disasters. We're not so good at preventing them. But preventing disease is the future of medicine. That’s the only way to lower costs and improve outcomes," Venter said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.